Contract Manufacturing Featured Articles

  1. Demon Customers, Meet The CMO Hourly Billing Machine
    5/22/2012

    Nearly all drug substance and drug product CMOs have moved to a working system that uses dedicated project managers. 

  2. Managing CMO Partnerships To Achieve Complex Production Objectives
    4/30/2012

    A strong CMO partnership requires a successful technology transfer, a clear understanding of the key objectives at each project life cycle stage, and effective management of unexpected events. By Ralph Lambalot, Ph.D.

  3. 5 Challenges CROs And Big Pharma Must Address
    4/9/2012
    Contract Research Organizations (CRO) have expanded their payroll by 122% in the past 10 years, accounting for 72,000 jobs in the United States and overseas, according to a study released by the Association of Clinical Research Organizations (ACRO). A Q&A With David Lathbury, Ph.D., VP of Chemical Development, AMRI
  4. Pharma Beyond Borders: India As An Outsourcing Destination
    2/1/2012
    The only thing that is constant in life (and that goes for the global pharma industry too!) is change. The need to access emerging markets with new and cost effective drugs, the diminishing blockbuster product model, and the far more complicated life cycle management programs are just some of the new and ever changing challenges that innovator pharmaceutical companies face in today’s environment. By Manoj Mehrotra
  5. Vaccine Update: New Technologies And Manufacturing Platforms Expand Protections
    2/1/2012

    Vaccines constitute a deeply explored and thoroughly tested technology that is now over 200 years old, dating from Edward Jenner’s first experiments with cowpox and smallpox during the 1790s. By Paul Di Filippo, JHP Pharmaceuticals

  6. Key Drivers For Outsourcing Partner Selection
    1/27/2012
    Each business has its own approach to outsourcing, from functional to full service, and often that approach is dependent on the requirements of a specific project. By Kate Hammeke, research manager, Nice Insight
  7. Understanding Ion Resin Technology
    1/23/2012
    Ion exchange resins have been in use for many years in pharmaceutical formulations. Their uses have ranged from simple excipients for tablet disintegration to the rate controlling function in extended release formulations. However, efficient drug utilization has been less than ideal historically in the formation of drug-resin complexes to be used in pharmaceutical products.
  8. Saudi Arabia Emerges As Pharma Manufacturing Hot Spot
    1/4/2012
    The World Bank/International Financial Corporation’s Doing Business report ranked the Kingdom of Saudi Arabia 12th in the world out of 183 economies for ease of doing business in 2011 — up from 67th in 2005. By Sara Gambrill
  9. New Global Pharmaceutical Outsourcing Trends
    12/29/2011
    It has been widely recognized that the global pharmaceutical industry is currently experiencing dynamic change. By Jim Zhang, Ph.D.
  10. Optimizing The Partner Selection Process For Drug Developers
    12/29/2011
    By the close of 2011, two prescription drug stories had picked up so much momentum that even people outside the pharmaceutical industry had heard about them in the news. One of these topics was the end of the patent life for a blockbuster drug and how the availability of generic versions means savings for drug consumers but comes at a cost for the drug developer. By Kate Hammeke, research manager, Nice Insight

1 2 3 4 5